Your browser doesn't support javascript.
loading
FASTOCH: Feasibility of Electronic Patient-Reported Outcomes in Older Patients With Cancer-A Multicenter Prospective Study.
Cancel, Mathilde; Sauger, Carine; Biogeau, Julie; Dardaine-Giraud, Véronique; Lecomte, Thierry; Solub, David; Combe, Pierre; Wilmet, Rémy; Aubard, Eugénie; Deloigne, Amandine; Hébrard, Philippe; Dorval, Étienne.
Afiliação
  • Cancel M; Department of Medical Oncology, Regional University Hospital Center, Tours, France.
  • Sauger C; Antenne d'OncoGériatrie, Regional Cancer Network, Regional University Hospital Center, Tours, France.
  • Biogeau J; Department of Geriatrics, Regional University Hospital Center, Tours, France.
  • Dardaine-Giraud V; Department of Geriatrics, Regional University Hospital Center, Tours, France.
  • Lecomte T; Department of Gastroenterology and Digestive Oncology, Regional University Hospital Center, Tours, France.
  • Solub D; CH de Chartres, Le Coudray, France.
  • Combe P; Recherche Oncologique Clinique 37 (ROC37), Centre d'Oncologie et Radiothérapie 37 (CORT37), Chambray-lès-Tours, France.
  • Wilmet R; Centre Saint Jean de Saint Doulchard, Saint-Doulchard, France.
  • Aubard E; CH de Châteauroux, Infirmière en Pratiques Avancées mention Oncologie, Châteauroux, France.
  • Deloigne A; DEDALUS HealthCare France, Saint-André-lez-Lille, France.
  • Hébrard P; Ana Health, Albi, France.
  • Dorval É; Antenne d'OncoGériatrie, Regional Cancer Network, Regional University Hospital Center, Tours, France.
J Clin Oncol ; 42(22): 2713-2722, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38709983
ABSTRACT

PURPOSE:

Multiple studies have demonstrated that electronic patient-reported outcomes (ePROs) improve overall survival and quality of life in cancer care. However, there are no specific prospective data on remote ePRO monitoring in the older population, although they represent a significant proportion of patients with cancer. PATIENTS AND

METHODS:

From February 2021 to April 2022, patients age 75 years and older under active anticancer treatment were consecutively recruited in six institutions. Remote ePRO feasibility was determined in intention-to-test (ITT) on the basis of the number of active users in the overall population. Primary failure applied to patients who had no Internet access or declined to test ePROs, while the other patients were assigned to the ITT population. Feasibility was also determined per-protocol on the basis of the number of active patients in the ITT population.

RESULTS:

Of the 473 patients included, primary failure applied to 288 patients (233 of whom had no Internet access). Among the 185 patients in ITT, 122 used ePROs, leading to a 26% feasibility in ITT and a 66% feasibility per protocol. In a multivariate analysis, the intent to test population was from a higher socioprofessional category (P = .009) and felt in better general condition in the Geriatric 8-score evaluation (P = .002). Active patients significantly differed from the inactive on their self-assessment of a better general condition (P < .001) only.

CONCLUSION:

Our multicenter study showed a limited feasibility rate (26%) of remote ePROs monitoring for older patients with cancer, mainly because of technology barriers. Yet, among the patients who did have Internet access, most of them indeed used ePROs (66%). Given the expected benefit of ePROs, the technology barriers therefore need to be lifted to improve cancer care in older patients.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Estudos de Viabilidade / Medidas de Resultados Relatados pelo Paciente / Neoplasias Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Estudos de Viabilidade / Medidas de Resultados Relatados pelo Paciente / Neoplasias Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: J Clin Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos